Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Melatonin may help treat PCOS symptoms in rats.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Alternative treatments show promise for hair growth beyond traditional methods.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Birth control pills can help reduce mild to moderate acne in women.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Using rodents for research shows that health problems in the womb can cause diseases later in life.